Metadate Cd Capsule, Extended Release
Product Images NDC 69654-580

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Metadate Cd (NDC 69654-580). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aytu Biopharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Metadate Cd 1)

Structural Formula (Metadate Cd 1)
Chemical structure diagram of methylphenidate hydrochloride showing its molecular framework including a phenyl ring, ester group, and piperidine ring with hydrochloride.*
FDA Label Image

60 mg Bottle Label (Metadate Cd 10)

60 mg Bottle Label (Metadate Cd 10)
Label for Metadate CD extended-release capsules, each containing 60 mg methylphenidate hydrochloride. The label shows the product name, dosage strength, capsule count of 30, and labeler Aytu BioPharma, Inc. It includes storage instructions to keep at 25°C with allowable excursions and a note about the Medication Guide requirement. Barcode and lot/revision details are also present.*
FDA Label Image

Figure1 (Metadate Cd 2)

Figure1 (Metadate Cd 2)
A line graph depicting mean methylphenidate plasma concentration (ng/mL) over time (hours) following dosing. It compares three regimens: 1 x 10 mg immediate release at 0 and 4 hours, 1 x 20 mg methylphenidate HCl extended-release capsule, and 2 x 20 mg methylphenidate HCl extended-release capsules (METADATE CD). The x-axis shows time after dosing from 0 to 9 hours, and the y-axis shows plasma concentration from 0 to 16 ng/mL.*
FDA Label Image

Figure 2 (Metadate Cd 3)

Figure 2 (Metadate Cd 3)
A bar graph comparing LS mean change from baseline between methylphenidate HCl extended-release capsules CD and placebo groups. The graph shows two bars: one for methylphenidate HCl capsules with a larger negative change and one for placebo with a smaller negative change, each accompanied by error bars and sample sizes (n=155 for methylphenidate, n=159 for placebo).*
FDA Label Image

Figure 3 (Metadate Cd 4)

Figure 3 (Metadate Cd 4)
A bar chart showing LS mean change from baseline comparing Methylphenidate HCl Extended-Release Capsules CD and placebo groups measured in the AM and PM. The chart includes error bars and quantifies the change for each group with Methylphenidate showing greater reduction values around -8.2 (AM) and -7.6 (PM) versus placebo at -1.5 (AM) and -0.9 (PM).*
FDA Label Image

10 mg Bottle (Metadate Cd 5)

10 mg Bottle (Metadate Cd 5)
Label for Metadate CD 10 mg extended-release capsules containing methylphenidate hydrochloride. The label indicates oral administration, once-daily dosing, and that the product is distributed by Aytu BioPharma, Inc. It contains 30 capsules per package, includes storage instructions at 25°C (77°F) with permitted excursions, and notes a Medication Guide is required for dispensing.*
FDA Label Image

20 mg Bottle Label (Metadate Cd 6)

20 mg Bottle Label (Metadate Cd 6)
Label for Metadate CD 20 mg extended-release capsules by Aytu BioPharma, Inc. The label includes the generic name methylphenidate HCl, dosage form as extended-release capsules, and a package count of 30 capsules. Storage instructions specify 25°C with permitted excursions. The label indicates a once-daily dosage and includes the NDC 69654-580-30.*
FDA Label Image

30 mg Bottle Label (Metadate Cd 7)

30 mg Bottle Label (Metadate Cd 7)
Label for METADATE CD 30 mg extended-release capsules containing methylphenidate hydrochloride. The label indicates once-daily dosing and includes storage instructions at 25°C with permitted excursions. Distributed by Aytu BioPharma, Inc., Denver, CO. The package contains 30 capsules and includes a barcode and product identifiers.*
FDA Label Image

40 mg Bottle Label (Metadate Cd 8)

40 mg Bottle Label (Metadate Cd 8)
METADATE CD 40 mg extended-release capsules packaging label, containing methylphenidate hydrochloride USP. The label indicates once-daily dosage, distributed by Aytu BioPharma, Inc., with 30 capsules per container. Storage instructions specify 25°C (77°F) with permitted excursions between 15°-30°C (59°-86°F). Includes a barcode and cautionary notes about not crushing or chewing the capsules.*
FDA Label Image

50 mg Bottle Label (Metadate Cd 9)

50 mg Bottle Label (Metadate Cd 9)
Label for Metadate CD 50 mg extended-release oral capsules containing methylphenidate hydrochloride. The label indicates once-daily dosing and includes a medication guide requirement. It is distributed by Aytu BioPharma, Inc. in Denver, CO, and comes in a package of 30 capsules. Storage instructions and barcode are visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.